Sales of anti-obesity drugs like Mounjaro and Wegovy are seeing a jump due to a surge in popularity, Business Standard ...

Sales of anti-obesity drugs like Mounjaro and Wegovy are seeing a jump due to a surge in popularity, Business Standard ...

Demand for weight-loss drugs is rising at a fast clip in India, where rivals Eli Lilly and Novo Nordisk are competing for market share, data from research firm Pharmarack showed on Monday.

The demand for obesity drugs in India is surging as Eli Lilly and Novo Nordisk compete. A Pakistani startup sends prosthetics ...

The health sector is witnessing notable developments, including the rising demand for obesity drugs in India as Eli Lilly and ...

Jessica Jani 3 min read 03 Jul 2025, 03:49 PM IST ...

In response to rising consumer complaints, India's drug regulator is set to implement new labelling norms for medicines that prioritise readability and help make informed choices ...

Mounjaro, priced between ₹14,000 and ₹17,500 per month, recorded sales of nearly ₹24 crore in its first three months, according to Indian pharma market data compiled by Pharmarack.

Between March and May, Lilly had sold 81,570 Mounjaro units in India. Meanwhile, Novo sold 1,788 units of Wegovy in India since its late-June launch with 25.3 million rupees in sales, Pharmarack said.

Sales of Lilly's Mounjaro, which launched in late March, doubled from May to June, reaching 87,986 units or 260 million rupees ($3.03 million), Pharmarack said in a virtual session. Between March ...